Home » US FDA Calls for Labeling Update for Elastomeric Infusion Devices
US FDA Calls for Labeling Update for Elastomeric Infusion Devices
December 14, 2009
Manufacturers of pumps to infuse local anesthetics must update their product labels to warn about a potential serious adverse effect when the pumps are
used for continuous intra-articular infusions, the U.S. Food and Drug Administration (FDA) says.
To View This Article:
Subscribe To International Medical Device Regulatory Monitor